Dermatología en Costa Rica

Monday, June 13, 2022

Síntomas de Rosacea Ocular

Published in Dermatology

Journal Scan / Research · June 12, 2022

Clinical Clues to Identify Patients With Ocular Rosacea

International Journal of Dermatology


TAKE-HOME MESSAGE

Abstract


BACKGROUND AND OBJECTIVES

Ocular rosacea is a special manifestation of rosacea with unknown etiology. Eye involvement in rosacea patients is surprisingly common; however, it is often underdiagnosed, resulting in inappropriate treatment. We aimed to provide an updated epidemiologic perspective on ocular rosacea in Germany to improve patient care.

PATIENTS AND METHODS

Data of 777 rosacea patients were assessed using a detailed online questionnaire regarding ocular and skin symptoms, previous dermatological and ophthalmological consults, presence of type 1 hypersensitivities, and Demodex testing. All data were statistically analyzed.

RESULTS

Most patients reported ocular symptoms (399/777, 51.4%), including red eyes (179/399, 44.9%), itching (187/399, 46.9%), sty or chalazion (309/399, 77.4%), and dryness (108/399, 27.1%). Ocular rosacea was confirmed in 149/309 cases who consulted an ophthalmologist (45.3%). A total of 159/399 (39.8%) had no pre-existing allergies. Eye involvement was significantly associated with the presence of skin symptoms (P < 0.05), impacting patients' general well-being and overall treatment satisfaction. About half of Demodex-positive patients (21/45, 46.7%) showed ocular symptoms.

CONCLUSIONS

Eye involvement in rosacea patients was common, often presenting with unspecific symptoms.


International Journal of Dermatology
Clinical clues to identify patients with ocular rosacea - a Germany-wide epidemiologic analysis
Int. J. Dermatol 2022 May 17;[EPub Ahead of Print], S Zierl, JA Hildebrand, A Guertler, C Dietrich, BM Clanner-Engelshofen, LE French, M Reinholz 

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]



<< Home